Related references
Note: Only part of the references are listed.Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing
Nicole Panarelli et al.
ENDOCRINE-RELATED CANCER (2019)
Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine
Anna E. Heverhagen et al.
NEUROENDOCRINOLOGY (2018)
Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis
Xin Zhou et al.
GENE (2018)
miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival
Yvonne Arvidsson et al.
MODERN PATHOLOGY (2018)
A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors
Anna Malczewska et al.
NEUROENDOCRINOLOGY (2018)
TGF-beta induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression
Silvia Ottaviani et al.
NATURE COMMUNICATIONS (2018)
The NETest The Clinical Utility of Multigene Blood Analysis - in the Diagnosis and Management of Neuroendocrine Tumors
Irvin M. Modlin et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)
Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer
Zebo Huang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors
Katarina Edfeldt et al.
NEUROENDOCRINOLOGY (2017)
A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer
Tao Zhu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma
Michaela Bowden et al.
ONCOTARGET (2017)
A panel of microRNA signature in serum for colorectal cancer diagnosis
Mingxia Zhu et al.
ONCOTARGET (2017)
MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer
Liwei Sun et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Analysis of miR-96 and miR-133a Expression in Gastrointestinal Neuroendocrine Neoplasms
Rakesh Mandal et al.
ENDOCRINE PATHOLOGY (2017)
Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours
Ashley Kieran Clift et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2016)
A Highly Predictive Model for Diagnosis of Colorectal Neoplasms Using Plasma MicroRNA: Improving Specificity and Sensitivity
Jane V. Carter et al.
ANNALS OF SURGERY (2016)
Lymphadenectomy during Small Bowel Neuroendocrine Tumor Surgery: The Concept of Skip Metastases
Arnaud Pasquer et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Cell-free microRNAs in blood and other body fluids, as cancer biomarkers
Blanca Ortiz-Quintero
CELL PROLIFERATION (2016)
MicroRNAs associated with small bowel neuroendocrine tumours and their metastases
Helen C. Miller et al.
ENDOCRINE-RELATED CANCER (2016)
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
Erika Larrea et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies
Irvin M. Modlin et al.
SURGERY (2016)
Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma
Edoardo D'Angelo et al.
ONCOTARGET (2016)
A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer
Ann Rita Halvorsen et al.
ONCOTARGET (2016)
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
Jeremie F. Cohen et al.
BMJ OPEN (2016)
Liver Metastases of Small Intestine Neuroendocrine Tumors Ki-67 Heterogeneity and World Health Organization Grade Discordance With Primary Tumors
Chanjuan Shi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract
I. M. Modlin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma
Cheng Wang et al.
SCIENTIFIC REPORTS (2015)
Circulating MicroRNA Biomarker Studies: Pitfalls and Potential Solutions
Kenneth W. Witwer
CLINICAL CHEMISTRY (2015)
Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs
Su-Chen Li et al.
PLOS ONE (2015)
Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
Marek Sochor et al.
BMC CANCER (2014)
Cancer biomarker discovery: Current status and future perspectives
Katrin Maebert et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2014)
MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling
Jin-tang Xia et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Recommendations for management of patients with neuroendocrine liver metastases
Andrea Frilling et al.
LANCET ONCOLOGY (2014)
The validity of circulating microRNAs in oncology: Five years of challenges and contradictions
J. Jarry et al.
MOLECULAR ONCOLOGY (2014)
Clinical relevance of circulating cell-free microRNAs in cancer
Heidi Schwarzenbach et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma
S. Tudor et al.
CELL DEATH & DISEASE (2014)
The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood
Irvin M. Modlin et al.
PLOS ONE (2013)
Metabonomic profiling: A novel approach in neuroendocrine neoplasias
James M. Kinross et al.
SURGERY (2013)
Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis
Ma Yuxia et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients
Han-Bo Le et al.
MEDICAL ONCOLOGY (2012)
Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
Hongjiang Wang et al.
PLOS ONE (2012)
Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center
Olov Norlen et al.
WORLD JOURNAL OF SURGERY (2012)
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
Mattia Boeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Nobuyoshi Kosaka et al.
CANCER SCIENCE (2010)
MicroRNA miR-125b causes leukemia
Marina Bousquet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma
Yusuke Yamamoto et al.
BIOMARKERS (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray
Michael J. Lodes et al.
PLOS ONE (2009)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Proteomics for biomarker discovery in acute kidney injury
Prosad Devarajan
SEMINARS IN NEPHROLOGY (2007)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Share Paper
